886 Blog posts found


A Sampling of Promising Cancer Science Highlighted at Major Meeting

MSK physician-scientists reported hopeful news from several clinical studies at the annual meeting of the American Association for Cancer Research.

MSK Physician-in-Chief José Baselga

In the Lab

Why a New Immunotherapy for Lung Cancer Works for Only Some People

According to an MSK study, a powerful immunotherapy drug for lung cancer works better in people whose tumors carry a lot of mutations caused by tobacco smoke.

Cancer genomics researcher Timothy Chan


Colorectal Cancer Screening Prevents Cancer, Saves Lives

Having a regular screening colonoscopy is your best defense against colon and rectal cancer.

A patient lies on an exam table while doctors in scrubs prepare to perform a colonoscopy.

In the Lab

Outsmarting Cancer’s Survival Skills

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.

MSK investigators Joan Massagué and Anna Obenauf

Learning Curve

Teaching Doctors to Think Like Patients

Memorial Sloan Kettering’s Comskil program helps doctors improve their communication skills — and their relationships with their patients.

Dermatologist Michael Marchetti speaks with a patient about treatment options for melanoma.


The Future of Cancer: Five Reasons for Optimism

Learn about five hot science areas that are changing the way we understand and treat cancer.

In the Clinic

“Living Therapies” Developed at MSK Provide New Approach for Cancer Treatment

Cell therapies that use patients’ own immune cells to attack cancer are a promising and rapidly growing area of research.

CAR T cell immunotherapy


Three Days in the Life of Memorial Sloan Kettering

While you’re watching the three-part Cancer: The Emperor of All Maladies, here’s an idea of what we’re doing to care for our patients.

Three Days in the Life of Memorial Sloan Kettering


Considering the Human Side — and the History — of Cancer

MSK employees previewed the upcoming documentary Cancer: The Emperor of All Maladies, which features several of our scientists and their research.

Pictured: Teresa Gilewski and filmmaker Barak Goodman


What Are Exceptional Responders?

When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.

Exceptional responders of new drugs in clinical trials.